AIF1 and Alzheimer disease: The translational potential of our observations was explored by comparing the IBA1 response in these experiments to IBA1 expression levels in 56 human cortical samples from neurocognitively normal donors as well as patients with early-onset AD (EOAD, onset < 65 years of age) and late-onset AD (LOAD, onset > 65 years of age).